Who invested in Fulcrum Therapeutics?
Fulcrum Therapeutics's investors include Fidelity, Perceptive Advisors, Foresite Capital, Casdin Capital and Samsara BioCapital, and 8 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$310Mraised across 3 rounds since 2016, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $80M sold, first sale Aug 2018
From Fulcrum Therapeutics's own website and the SEC filings it signed: 12 on the team.
On the board, as filediAlan EzekowitzJames CollinsKatina DortonMark Levin
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Fulcrum Therapeutics's investors include Fidelity, Perceptive Advisors, Foresite Capital, Casdin Capital and Samsara BioCapital, and 8 more on record.
Fulcrum Therapeutics has raised $310M across 3 rounds since 2016.
Fulcrum Therapeutics's most recent round was an Undisclosed round of $175M in Dec 2025.
Its most recent round, $175M in Dec 2025, is also its largest on record.
Fulcrum Therapeutics's first round on record, in Jul 2016, was backed by Third Rock Ventures.
Fulcrum Therapeutics's latest named round is an Undisclosed round, in Dec 2025.
Fulcrum Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.